← Back to Search

Behavioural Intervention

Active tDCS with guided imagery for Chronic Pain

N/A
Waitlist Available
Led By Kenneth M Peters, MD
Research Sponsored by William Beaumont Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 48 hours
Awards & highlights

Study Summary

This trial is testing whether a non-invasive brain stimulation therapy called transcranial direct current stimulation (tDCS), when combined with a relaxation technique called guided imagery, can help reduce chronic pelvic pain.

Eligible Conditions
  • Chronic Pain
  • Pelvic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To access the acute changes in EEG alpha brain waves in women with CPP after 1 session of each of the following treatments: (1) active tDCS + GI, (2) sham tDCS + GI, (3) sham tDCS alone (no GI) and (4)active tDCS alone (no GI).
Secondary outcome measures
To access acute changes in pain in women with CPP after 1 session of each of the following treatments: (1) active tDCS + GI, (2) sham tDCS + GI, (3) sham tDCS alone (no GI) and (4)active tDCS alone (no GI).

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Active tDCS with guided imageryExperimental Treatment1 Intervention
Subjects will receive 2 milliamps of electrical stimulation to the brain (transcranial direct stimulation-tDCS) for 20 minutes concurrently while listening to a guided imagery CD specifically designed for women with chronic pelvic pain.
Group II: Active tDCS alone (no guided imagery)Experimental Treatment1 Intervention
Subjects will receive 2 milliamps of electrical stimulation to the brain (transcranial direct stimulation-tDCS) for 20 minutes while remaining seated, no guided imagery will be provided.
Group III: Sham tDCS with guided imageryPlacebo Group1 Intervention
Subjects will receive 2 milliamps of electrical stimulation to the brain (transcranial direct stimulation-tDCS) for only 30 seconds and then the device will turn off. The device will remain in place, however, for 25 minutes the subject listens to a guided imagery CD specifically designed for women with chronic pelvic pain.
Group IV: Sham tDCS alone (no guided imagery)Placebo Group1 Intervention
Subjects will receive 2 milliamps of electrical stimulation to the brain (transcranial direct stimulation-tDCS) for only 30 seconds and then the device will turn off. The device will remain in place, however, for 25 minutes the subject will remain seated, no guided imagery will be provided.

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor
149 Previous Clinical Trials
112,858 Total Patients Enrolled
2 Trials studying Chronic Pain
916 Patients Enrolled for Chronic Pain
Kenneth M Peters, MDPrincipal InvestigatorBeaumont Health
12 Previous Clinical Trials
4,320 Total Patients Enrolled
1 Trials studying Chronic Pain
666 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of the Acute Effects of Guided Imagery and tDCS on Pain Levels in Women With Chronic Pelvic Pain
Kenneth M Peters, MD 2020. "Study of the Acute Effects of Guided Imagery and tDCS on Pain Levels in Women With Chronic Pelvic Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04250662.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top